Monograph: Ambrisentan

Ambrisentan

Die Inhalte stehen nur registrierten Benutzern zur Verfügung.

Sie sind zum ersten mal hier und möchten die Datenbank 10-Tage kostenlos testen, dann registrieren Sie sich einmalig. Nach der Registrierung melden Sie sich mit Ihrem Benutzernamen und Passwort an.

Sie sind bereits bei DrugBase registriert und möchten diese Datenbank 10-Tage kostenlos und unverbindlich testen? Dann melden Sie sich mit Ihren Zugangsdaten an und wählen Sie anschließend die Datenbank, die Sie testen möchten.

Full Title

Ambrisentan

Generic Name

Ambrisentan

Chemical Name

...

Classification

CAS Number

...

Introduction

Introduction

...

...

Description

...

...

Uses

Uses

...

Pulmonary Arterial Hypertension

...

Pulmonary Fibrosis

...

...

Dosage and Administration

Dosage and Administration

...

General

...

Restricted Distribution Program

...

Administration

...

Oral Administration

...

Dosage

...

Pulmonary Arterial Hypertension

...

Special Populations

...

...

Cautions

Cautions

...

Contraindications

...

Warnings/Precautions

...

Warnings

...

Fetal/Neonatal Morbidity and Mortality

...

Other Warnings and Precautions

...

Fluid Retention

...

Fertility in Males

...

Hematologic Effects

...

Pulmonary Effects

...

Hepatic Effects

...

Specific Populations

...

Pregnancy

...

Lactation

...

Pediatric Use

...

Geriatric Use

...

Hepatic Impairment

...

Renal Impairment

...

Common Adverse Effects

...

...

Drug Interactions

Drug Interactions

...

Drugs Affecting Hepatic Microsomal Enzymes

...

Inhibitors or Inducers of CYP2C19

...

Inhibitors or Inducers of CYP3A4

...

Drugs Affecting the Organic Anion Transport Protein

...

Drugs Affecting the P-glycoprotein Transport System

...

Drugs Affecting Uridine 5′-Diphosphate Glucuronosyltransferase Enzymes

...

Cyclosporine

...

Digoxin

...

Ketoconazole

...

Mycophenolate Mofetil

...

Omeprazole

...

Hormonal Contraceptives

...

Phosphodiesterase Inhibitors

...

Rifampin

...

Ritonavir

...

Tacrolimus

...

Warfarin

...

...

Advice to Patients

Advice to Patients

...

...

Preparations

Preparations

...

Ambrisentan

...

...

Common general statement Elements

Additional Information

...

...

REMS

...

References

References

...

...

Copyright

AHFS® Drug Information. © Copyright, 1959-2020, Selected Revisions January 7, 2019. American Society of Health-System Pharmacists, Inc., 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.

† Use is not currently included in the labeling approved by the US Food and Drug Administration.

Quelle

AHFS Drug Information